Carmen Beatrice Pearman Arlt, LMSW, CAC, CMA 1955 – 2019

Carmen Beatrice Pearman Arlt, LMSW, CAC, CMA 1955 – 2019

National Alliance for Medication Assisted RecoveryPress Release
Contacts Persons: Joycelyn Woods, Executive Director, [email protected]Carmen Pearman-Arlt, President, [email protected]♰Phone/Fax: 1.212.595.NAMA  (1-212-595-62620
For ReleaseMay 6, 2019

64, passed away December 9, 2018 after a long illness.
In the early 1990s NAMA Recovery was mailed an index card with dimes taped to it and a short message saying they could not afford $10 for membership and this was all they had.  It was Carmen Pearman. Like all letters we receive from patients she received a letter back saying that we would rather have her advocacy than money.   
Carmen organized one of our oldest chapters The MAG (Methadone Advocacy Group). One of the things the group decided to do was clean the street around their clinic.  While they were out picking up garbage and sweeping the street when the Reverend from the church across the street came out to warn them about those addicts over there. Carmen explained that they were those addicts. From this encounter patients were given space in the church to set up 12 step groups and to have meetings. The following year there was a big drug conference In Indiana and the chapter acted as the color guard for the governor when he entered the arena. I remember Carmen sending a picture of them all dressed in white shirts, navy bow ties for women and regular ties for men and navy pants.
Carmen went back to school and earned an MSW and was continuing her education a PhD in social work when she became ill.

She received the Dole Nyswander Award (Marie) in 2001 for organizing the state provider organization. The state of Indiana had no representation and clinics saw each other more as competitors than associates working for a common cause. She helped to establish the clinics in their current state organization.The past few years she developed the program for women and children at Porter Starke (Valparaiso, IN) in addition to being President of NAMA Recovery.

She resided in Hanna, Indiana and is survived by two sons: David and Erich and three great-grandchildren.
NAMA Recovery will miss Ms. Pearman’s  dedication and compassion to patients and the field.
(Information for this Press Release was published in the Post Tribune on Feb. 10, 2019.)
Support NAMA Recovery – become a Member

Posted by Joycelyn Woods, Executive Director at 5:33 PMNo comments:

 

Similar Posts

  • TEXNAMA

    Admin 08/25/2021

    Texas Alliance of Methadone Advocates We are dedicated to educating all methadone patients, counselors, familes, employers about the benefits of methadone. We are volunteers made up of patients, ex-patients, family members, employers, counselors, providers, doctors and you. We want to end the stigma associated with being on Methadone Maintence Treatment (MMT) by educating both patients…

  • Answer one

    Admin 12/31/2022

    FALSE! Current research shows that doses below 60 mg/day are “not effective and hence not appropriate” and that low dose policies for pregnant and non-pregnant patients are associated with increased drug use as well as reduced program retention. Medical withdrawal of opioid dependent women is not recommended in pregnancy because of increased risk to the…

  • Methadone, HIV Infection and Immune Function by Herman Joseph

    Admin 04/18/2023

    Education Series Number 4 April 1994 Herman Joseph, Ph.D. was part of the original team that started methadone treatment at The Rockefeller University. His research and publications have had a major influence on methadone treatment. After leaving the research team at Rockefeller University Dr. Joseph started and administered a methadone clinic for patients on probation…

  • |

    FOR IMMEDIATE RELEASE

    Admin 01/30/2022

    October 9, 2002 NIDA Contact: Michelle Person 301-443-6245 SAMHSA Contact: Leah Young 301-443-8956 NIDA Research and SAMHSA Physician Training Combine to Put Care for Opiate Dependence in Hands of Family Doctor. Buprenorphine, a new medication developed through more than a decade of research supported by the National Institute on Drug Abuse (NIDA), will now become…